Professor
University of Pittsburgh School of Medicine
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Michael Green, MD, MPH, is Professor, Pediatrics and Surgery at the University of Pittsburgh School of Medicine. His clinical and research interest have focused on the prevention and treatment of infections in immunocompromised children with a focus on children undergoing solid organ transplant, hematopoetic cell transplant and those being treated for cancer. He has a particular interest in EBV-associated Post-Transplant Lymphoproliferative Disorders (PTLD) and is co-editor of the first and second edition of the only textbook dedicated to this topic. He has also served as a member of the Type 1 Diabetes Trial Network helping to address risks and benefits of numerous types of immunosuppressive therapy as treatment and prevention for Type 1 Diabetes. He has published more than 160 peer-reviewed articles and more than 70 review articles and textbook chapters. He was co-editor of the first edition and more recently editor-in-chief of the 4th edition of the Guidelines for the Prevention and Management of Infectious Complications of Solid Organ Transplantation published by the American Society of Transplantation. Dr Green has consistently received grant funding for his work since 1987.
